Atlas Trials

The Efficacy of Chemotherapy Combined With Immunocheckpoint Inhibitors in Advanced Biliary Malignancies

Clinical trial NCT05487443 · UNKNOWN

Trial details

NCT number
NCT05487443
Sponsor
First People's Hospital of Hangzhou
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
GemcitabineBiliary Tract CancerImmune Checkpoint Inhibitors
Start date
2022-08-01
Primary completion
2023-09-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.